AR and neoplasm: Immunohistochemistry (IHC) staining of these tumor samples showed a significant reduction of UBE2J1, accompanied by an increase in AR and AR target NKX3.1 proteins, in PCa compared to matched benign prostate tissue (Fig. 6J).